日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer

ZEB2 依赖的 EMT 转录程序通过激活结直肠癌中的核苷酸切除修复基因 ERCC1 和 ERCC4 来驱动治疗耐药性

Rahul Sreekumar, Hajir Al-Saihati, Muhammad Emaduddin, Karwan Moutasim, Massimiliano Mellone, Ashish Patel, Seval Kilic, Metin Cetin, Sule Erdemir, Marta Salgado Navio, Maria Antonette Lopez, Nathan Curtis, Tamer Yagci, John N Primrose, Brendan D Price, Geert Berx, Gareth J Thomas, Eugene Tulchinsky

Protein kinase C inhibitors override ZEB1-induced chemoresistance in HCC

蛋白激酶 C 抑制剂可抑制 ZEB1 诱导的肝细胞癌化学耐药性

Rahul Sreekumar, Muhammad Emaduddin, Hajir Al-Saihati, Karwan Moutasim, James Chan, Marcello Spampinato, Rahul Bhome, Ho Ming Yuen, Claudia Mescoli, Alessandro Vitale, Umberto Cillo, Massimo Rugge, John Primrose, Mohammad Abu Hilal, Stephen Thirdborough, Eugene Tulchinsky, Gareth Thomas, Alex Mirnez

HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity

HDMX-L 由 HDMX 基因第一个内含子中的功能性 p53 反应启动子表达,并参与自调节反馈回路以控制 p53 活性

Anna Phillips, Amina Teunisse, Suzanne Lam, Kirsten Lodder, Matthew Darley, Muhammad Emaduddin, Anja Wolf, Julia Richter, Job de Lange, Matty Verlaan-de Vries, Kristiaan Lenos, Anja Böhnke, Frank Bartel, Jeremy P Blaydes, Aart G Jochemsen

Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells

Odin (ANKS1A) 是结直肠癌细胞中的 Src 家族激酶靶标

Muhammad Emaduddin, Mariola J Edelmann, Benedikt M Kessler, Stephan M Feller

Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells

结直肠癌细胞中的细胞生长、整体磷酸酪氨酸升高以及通过 Src 家族激酶进行的 c-Met 磷酸化

Muhammad Emaduddin, David C Bicknell, Walter F Bodmer, Stephan M Feller